Nutriband stock more than doubles on Korean patent approval for core tech

Nutriband

31/12/2021 15:09

** Shares of Nutriband  NTRB.O , which develops transdermal
pharma products, up 117% at $8.49 – set for their best day since
October 2019
    ** Co says Korean Intellectual Property Office (KIPO) fully
issued its patent titled "Abuse and Misuse Deterrent Transdermal
System", related to the co's lead technology AVERSA
    ** Up to Thursday's close, NTRB stock declines 74% YTD

 (Reporting by Yuvraj Malik in Bengaluru)
 ((yuvraj.malik@thomsonreuters.com))